Cargando…
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
Malignant mesothelioma (MM) constitutes a very aggressive tumor that arises from the pleural or peritoneal cavities and is highly refractory to conventional therapies. Several key genetic alterations are associated with the development and progression of MM including mutations of the CDKN2A/ARF, NF2...
Autor principal: | Sekido, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923345/ https://www.ncbi.nlm.nih.gov/pubmed/29565815 http://dx.doi.org/10.3390/cancers10040090 |
Ejemplares similares
-
NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
por: Sato, Tatsuhiro, et al.
Publicado: (2018) -
TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
por: Fujii, Makiko, et al.
Publicado: (2012) -
Aberrant expression of
NPPB
through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations
por: Sato, Tatsuhiro, et al.
Publicado: (2023) -
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
por: Kodama, Yuta, et al.
Publicado: (2021) -
Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade
por: Fujii, Makiko, et al.
Publicado: (2012)